Indivior Inc. – Trademark Portfolio
Entity Type: 03
Indivior Inc. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include OPVEE and OPIANT. The owner is based in North Chesterfield, VA.
10710 Midlothian Turnpike
North Chesterfield, VA 23235
Showing of trademarks Trademarks
Trademark Classifications
Indivior Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Indivior Inc. have?
Indivior Inc. has 10 U.S. trademarks filed with the USPTO. Of these, 5 registered, 5 abandoned.
What trademark classes does Indivior Inc. file in?
Indivior Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 44 (Medical Services), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Indivior Inc.'s most well-known trademarks?
Indivior Inc.'s registered trademark portfolio includes well-known marks such as OPVEE and OPIANT. These are among 5 currently registered trademarks in the portfolio.
What is Indivior Inc.'s trademark registration success rate?
Indivior Inc. has a 50% trademark registration rate, with 5 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.